22-50447199-G-A
Variant names:
Variant summary
Our verdict is Benign. Variant got -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BS1BS2
The NM_002972.4(SBF1):c.5625C>T(p.Asp1875Asp) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00339 in 1,613,808 control chromosomes in the GnomAD database, including 21 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Genomes: 𝑓 0.0020 ( 2 hom., cov: 33)
Exomes 𝑓: 0.0035 ( 19 hom. )
Consequence
SBF1
NM_002972.4 synonymous
NM_002972.4 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: 0.0960
Genes affected
SBF1 (HGNC:10542): (SET binding factor 1) This gene encodes a member of the protein-tyrosine phosphatase family. However, the encoded protein does not appear to be a catalytically active phosphatase because it lacks several amino acids in the catalytic pocket. This protein contains a Guanine nucleotide exchange factor (GEF) domain which is necessary for its role in growth and differentiation. Mutations in this gene have been associated with Charcot-Marie-Tooth disease 4B3. Pseudogenes of this gene have been defined on chromosomes 1 and 8. [provided by RefSeq, Dec 2014]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -21 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.49).
BP6
Variant 22-50447199-G-A is Benign according to our data. Variant chr22-50447199-G-A is described in ClinVar as [Likely_benign]. Clinvar id is 718820.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr22-50447199-G-A is described in Lovd as [Benign].
BP7
Synonymous conserved (PhyloP=0.096 with no splicing effect.
BS1
Variant frequency is greater than expected in population nfe. gnomad4 allele frequency = 0.00203 (309/152340) while in subpopulation NFE AF= 0.00373 (254/68026). AF 95% confidence interval is 0.00336. There are 2 homozygotes in gnomad4. There are 122 alleles in male gnomad4 subpopulation. Median coverage is 33. This position pass quality control queck.
BS2
High Homozygotes in GnomAd4 at 2 AR gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SBF1 | NM_002972.4 | c.5625C>T | p.Asp1875Asp | synonymous_variant | Exon 41 of 41 | ENST00000380817.8 | NP_002963.2 | |
SBF1 | NM_001410794.1 | c.5628C>T | p.Asp1876Asp | synonymous_variant | Exon 41 of 41 | NP_001397723.1 | ||
SBF1 | NM_001365819.1 | c.5550C>T | p.Asp1850Asp | synonymous_variant | Exon 40 of 40 | NP_001352748.1 | ||
SBF1 | NM_001410795.1 | c.5547C>T | p.Asp1849Asp | synonymous_variant | Exon 40 of 40 | NP_001397724.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.00203 AC: 309AN: 152222Hom.: 2 Cov.: 33
GnomAD3 genomes
AF:
AC:
309
AN:
152222
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00257 AC: 638AN: 248306Hom.: 5 AF XY: 0.00272 AC XY: 367AN XY: 135064
GnomAD3 exomes
AF:
AC:
638
AN:
248306
Hom.:
AF XY:
AC XY:
367
AN XY:
135064
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00353 AC: 5164AN: 1461468Hom.: 19 Cov.: 32 AF XY: 0.00353 AC XY: 2567AN XY: 727064
GnomAD4 exome
AF:
AC:
5164
AN:
1461468
Hom.:
Cov.:
32
AF XY:
AC XY:
2567
AN XY:
727064
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00203 AC: 309AN: 152340Hom.: 2 Cov.: 33 AF XY: 0.00164 AC XY: 122AN XY: 74490
GnomAD4 genome
AF:
AC:
309
AN:
152340
Hom.:
Cov.:
33
AF XY:
AC XY:
122
AN XY:
74490
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
2
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign/Likely benign
Submissions summary: Benign:7
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:5
Jan 22, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing
- -
-
Genome Diagnostics Laboratory, University Medical Center Utrecht
Significance: Likely benign
Review Status: no assertion criteria provided
Collection Method: clinical testing
- -
Dec 21, 2020
GeneDx
Significance: Likely benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing
- -
-
Breakthrough Genomics, Breakthrough Genomics
Significance: Likely benign
Review Status: criteria provided, single submitter
Collection Method: not provided
- -
Oct 01, 2024
CeGaT Center for Human Genetics Tuebingen
Significance: Likely benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing
SBF1: BP4, BP7, BS2 -
not specified Benign:1
-
Clinical Genetics, Academic Medical Center
Significance: Benign
Review Status: no assertion criteria provided
Collection Method: clinical testing
- -
Charcot-Marie-Tooth disease type 4B3 Benign:1
Aug 10, 2020
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
RBP_binding_hub_radar
RBP_regulation_power_radar
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at